Orakl Oncology (private company)
See something wrong or missing? Let us know
Offices:Paris
Business model:B2BSAAS
Orakl Oncology is a biotech startup from France developing a techbio platform that integrates best-in-class biology with real-world patient data at scale to accurately model tumors and accelerate oncology drug development.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 14.91M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Orakl Oncology
Name | Criteria | |
---|---|---|
![]() |
Molecule.one
75%
|
|
![]() |
Solvemed
75%
|
|
![]() |
Seqstant
75%
|
|
![]() |
Rivia
75%
|
|
![]() |
Generare
75%
|
|
![]() |
Biorce
75%
|
|
![]() |
Kuano
72%
|
|
![]() |
OxDX
72%
|
|
![]() |
Biotx AI
72%
|
|
![]() |
Sable Bio
72%
|
|